Dr. Vicki L. Ellingrod Named Associate Dean for Research and Graduate Education
Vicki L. Ellingrod, PharmD, FCCP, has been named associate dean for research and graduate education at the University of Michigan College of Pharmacy. She currently serves as the John Gideon Searle Professor of Clinical and Translational Psychiatry in the Clinical Pharmacy Department. Dr. Ellingrod is also the associate director for the Michigan Institute for Clinical and Health Research (MICHR), which is funded by a Clinical and Translational Science Awards (CTSA) from the National Center for the Advancement of Translational Science (NCATS).
Dr. Ellingrod earned her BS and PharmD from the University of Minnesota. She completed a postdoctoral fellowship in psychopharmacology/pharmacogenetics at the University of Iowa before joining the faculty as an assistant professor. Dr. Ellingrod moved to the University of Michigan in 2006.
“The College is such a unique institution,” says Dr. Ellingrod. “Under one roof we have research that spans the entire translational spectrum, from basic research which also focuses on drug discovery, to outcome experts working within the medication use process, and the policy and practice of pharmacy. My goal is to facilitate a research environment that will allow faculty to capitalize on their strengths and synergize their research endeavors so we can continue to be at the forefront of pharmacy and drug research.”
“Within the next three years, I have set three goals,” explains Dr. Ellingrod. “Primarily, to provide the infrastructure necessary for our faculty to have successfully research programs. Secondly, begin discussing novel models for post-graduate and graduate education. And lastly, synergize our research efforts through facilitating greater collaborative efforts between COP faculty.”
“I'm thrilled that Vicki has formally joined our leadership team,” says James Dalton, PhD, dean and professor of pharmaceutical sciences. “Vicki's achievements as a researcher, scholar, educator, and mentor position her well for success in this role, as does her prominent role in MICHR, U-M's CTSA, and other units across campus.”
Dr. Ellingrod’s research has primarily focuses on the pharmacogenomics of mental health treatments. She was recently appointed to President Schlissel’s Precision Medicine Task force. She is a founding member of the College of Psychiatric and Neurologic Pharmacists and a full member of the American College of Neuropsychopharmacology. Dr. Ellingrod also serves as a scientific editor for Pharmacotherapy. She has also acted as Director of the U-M Clinical Pharmacogenomics Laboratory for the past 10 years. Recently Dr. Ellingrod was appointed as an Associate Editor for the 10th edition of the DiPiro text book Pharmacotherapy, a Pathophysiologic Approach. She will assume a full editor position for the 11th edition in 2018.